Enhancement of shelf life and handling properties of drug nanoparticles: Nanoscale mixing of itraconazole with silica

Industrial and Engineering Chemistry Research

Volumn 47, Issue 14, 2008, Pages 4717-4725

  Sanganwar, Ganesh P ^a   Gupta, Ram B ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-FUNGAL; DEAGGLOMERATION; DRUG NANOPARTICLES; ENHANCED MASS TRANSFER; FLOW-ABILITY; HANDLING PROPERTIES; ITRACONAZOLE; NANO SCALING; NANOFLAKES; NANOSCALE LEVELS; RAPID DEPRESSURIZATION; SHELF-LIFE; SILICA NANO-PARTICLES; SUPER-CRITICAL; SUPERCRITICAL ANTI-SOLVENT; SUPERCRITICAL CARBON DIOXIDE;

CARBON DIOXIDE; CHEMOTHERAPY; DRUG DELIVERY; DRUG DOSAGE; MIXING; NANOPARTICLES; NANOSTRUCTURES; NANOTECHNOLOGY; SILICA; SILICATE MINERALS; SILICON COMPOUNDS; SUPERCRITICAL FLUID EXTRACTION;

NANOSTRUCTURED MATERIALS;

EID: 49249135787     PISSN: 08885885     EISSN: None     Source Type: Journal    
DOI: 10.1021/ie8000343     Document Type: Article

References (48)

1. Amidon, G. L.; Lennernas, H.; Shah, V. P.; Crison, J. R. A theoretical basis for a biopharmaceutical drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 1995, 12, 413-420.
2. Liversidge, G. G.; Cundy, K. C. Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: absolute oral bioavailability of nanocrystalline Danzol in beagle dogs. Int. J. Pharm. 1995, 125, 91-97.
3. Jounela, A.; Pentikainen, P.; Sothmann, A. Effect of particle size on the bioavailability of digoxin. Eur. J. Clin. Pharmacol. 1975, 8, 365-370.
4. Rasenack, N.; Muller, B. W. Dissolution rate enhancement by in situ micronization of poorly water-soluble drugs. Pharm. Res. 2002, 19 (12), 1894-1900.
5. Finholt, P.; Slovang, S. Dissolution kinetics of drugs in human gastric juice the role of surface tension. J. Pharm. Sci. 1968, 57, 1322-1326.
6. Aguiar, A. J.; Zehner, A. W.; Kinkel, A. W. Deaggregation behavior of a relatively insoluble substituted benzoic acid and its sodium salt. J. Pharm. Sci. 1967, 56 (10), 1243-1252.
7. Swanepoel, E.; Liebenberg, W.; De Villiers, M. M.; Dekker, T. G. Dissolution properties of proxicam powders and capsules as a function of particle size and the agglomeration of powders. Drug. Dev. Ind. Pharm. 2000, 26 (10), 1067-1076.
8. Ticehurst, M. D.; Basford, P. A.; Dallman, G I.; Lukas, T. M.; Marshall, P. V.; Nichols, G.; Smith, D. Characterisation of the influence of micronization on the crystallinity and physical stability of revatropate hydrobromide. Int. J. Pharm. 2000, 193, 247-259.
9. De Villiers, M. M. Influence of agglomeration of cohesive particles on the dissolution behaviour of furosemide powder. Int. J. Pharm. 1996, 136, 175-179.
10. De Villiers, M. M.; Van der Watt, J. G. The measurement of mixture homogeneity and dissolution to predict the degree of drug agglomerate breakdown achieved through powder mixing. Pharm. Res. 1994, 11 (11), 1557-1561.
11. Prescott, J. K.; Barnum, R. A. On powder flowability. Pharm. Technol. 2000, 10, 60-84.
12. Thalberg, K.; Lindholm, D.; Axelsson, A. Comparison of different flowability tests for powders for inhalation. Powder Technol. 2004, 146, 206-213.
13. Harnby, N.; Edwards, M. F.; Nienow, A. W. Mixing in Process Industries; Butterworth: London, 1990; p 90.
14. Krycer, I.; Hersey, J. A. A comparative study of comminution in rotary and vibratory ball mills. Powder Technol. 1980, 27, 137-141.
15. Krycer, I.; Hersey, J. A. Fine powder mixing in vibratory ball mill. Int. J. Pharm. 1980, 6 (2), 119-129.
16. Harnby, N. An engineering view of pharmaceutical powder mixing. Pharm. Sci. Technol. Today 2000, 3 (9), 303-309.
17. Wei, D.; Dave, R.; Pfeffer, R. Mixing and characterization of nanosized powders: An assessment of different techniques. J. Nanopart. Res. 2002, 4, 21-41.
18. Yang, J.; Wang, Y.; Dave, R. N.; Pfeffer, R. Mixing of nano-particles by rapid expansion of high-pressure suspensions. Adv. Powder Technol 2003, 14 (4), 71-93.
19. Gupta, R. B.; Chattopadhyay, P. Method of forming nanoparticles and microparticles of controllable size using supercritical fluids with enhanced mass transfer, U.S. Patent 6,620,351, 2003.
20. Watanabe, H.; Ghadiri, M.; Matsuyama, T.; Ding, L. Y.; Pitt, K. G.; Maruyama, H.; Matsusaka, S.; Masuda, H. Triboelectrification of pharmaceutical powders by particle impact, Int. J. Pharm. 2007, 334, 149-155.
21. Always, B.; Sangchantra, R.; Stewart, P. J. Modeling the dissolution of diazepam in lactose interactive mixtures. Int. J. Pharm. 1996, 130, 213-224.
22. Westerberg, M.; Nystrom, C. Physicochemical aspects of drug release. Part 18. Use of a surfactant and disintegrants for improving drug dissolution rate from ordered mixtures. STP Pharma Sci. 1993, 3, 142-147.
23. Liu, J.; Stewart, J. Deaggregation during dissolution of benzodiazepines in interactive mixtures. J. Pharm. Sci. 1998, 87 (12), 1632-1638.
24. Stewart, P. J.; Zhao, F-Y. Understanding agglomeration of indomethacin during the dissolution" of micronised indomethacin mixtures through dissolution and de-agglomeration modeling approaches. Eur. J. Pharm. Biopharm. 2005, 59, 315-323.
25. Zimmermann, I.; Meyer, K. Effect of glidants in binary powder mixtures. Powder Technol. 2004, 139, 40-54.
26. Jonat, S.; Hasenzahl, S.; Drechsler, M.; Albers, P.; Wagner, K. G.; Schmidt, P. G Investigation of compacted hydrophilic and hydrophobic colloidal silicon dioxides as glidants for pharmaceutical excipients. Powder Technol. 2004, 141, 31-43.
27. Yang, J.; Silva, A.; Banerjee, A.; Dave, R. N.; Pfeffer, R. Dry particle coating for improving the flowability of cohesive powders. Powder Technol. 2005, 158, 21-33.
28. Cabot Corporation, Influence of CAB-O-SIL M-5P on the angle of repose and flow rates of the pharmaceutical powders, www.cabot-corp.com/../ cba118004158bled8525&7a005021b1/$FILE/TD-176%20Angle.pdf, 2007.
29. Wishart, D. S.; Konx, C.; Guo, A. C.; Shrivastava, S.; Hassanali, M.; Stothard, P.; Chang, Z.; Woolsey, J. Drugbank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 2006, 1 (34), D668-D672.
30. United States Pharmacopeial Convention. In vitro and in vivo evaluation of dosage forms. USP 28. Presented at the United States Pharmacopeial Convention, Rockville, MD, 2005; Paper No. 1088.
31. Chattopadhyay, P.; Gupta, R. B. Protein nanoparticles formation by supercritical antisolvent with enhanced mass transfer. AIChE J. 2002, 48, 235-244.
32. 2 antisolvent with enhanced mass transfer. Int. J. Pharm. 2001, 228 (1-2), 19-31.
33. 2-Based Production of Fullerene Nanoparticles. Ind. Eng. Chem. Res. 2000, 39 (7), 2281-2289.
34. Sacha, G. A.; Schmitt, W. J.; Nail, S. L. Identification of critical process variables affecting particle size following precipitation using a supercritical fluid. Pharm. Dev. Technol. 2006, 11, 187-194.
35. Kim, M.-S.; Lee, S.; Park, J.-S.; Woo, J.-S.; Hwang, S.-J. Micronization of cilostazol using supercritical antisolvent process: effect of process parameters. Powder Technol. 2007, 177, 64-70.
36. Reverchon, E.; De Marco, I. Supercritical antisolvent precipitation of cephalosporins. Powder Technol. 2006, 164, 139-146.
37. Brandt, O.; Rajahusmi, A. M.; Roth, P. First observations on break up of particle agglomerates in shock waves. Exp. Fluids 1987, 5, 86-94.
38. Nichols, G.; Byard, S.; Bloxham, M. J.; Botterill, J.; Dawson, N. J.; Dennis, A.; Diart, V.; North, N. C.; Sherwood, J. D. A review of the terms agglomerate and aggregate with a recommendation for nomenclature used in powder and particle characterization. J. Pharm. Sci. 2002, 97 (10), 2103-2109.
39. Bhattachar, S. N.; Hedden, D. B.; Olsofsky, A. M.; Qu, X.; Hsieh, W.-Y.; Canter, K. G. Evaluation of the vibratory feeder method for assessment of powder flow properties. Int. J. Pharm. 2004, 269, 385-392.
40. Geldart, D.; Wouters, I. M. F. Characterising semi-cohesive powders using angle of repose. Part. Part. Syst. Charact. 1996, 13, 254-259.
41. Schussele, A.; Bauer-Brandl, A. Note on the measurement of flowability according to the European pharmocoepia. Int. J. Pharm. 2003, 257, 301-304.
42. Amidon, G. E.; Bergren, M. S.; Grant, D. J. W.; Marshall, K.; Itai, S. Physical test methods for powder flow characterization of pharmaceutical materials: A review of methods. Pharmacopeial Forum 1999, 25 (3), 8298-8308.
43. Lindberg, N.-O.; Palsson, M.; Pihl, A.-C.; Freeman, R.; Freeman, T.; Zetzener, H.; Enstad, G. Flowability measurements of pharmaceutical powder mixtures with poor flow using five different techniques. Drug Dev. Ind. Pharm 2004, 30 (7), 785-791.
44. Lisenbuhler, M.; Wirth, K.-E. An innovative dry powder coating process in non-polar liquids producing tailor made micro-particles. Powder Technol. 2005, 158, 3-20.
45. Miller, D. A.; McConville, J. T.; Yang, W.; Williams, R. O., III.; McGinity, J. W. Hot-melt extrusion for enhanced delivery of drug particles. J. Pharm. Sci. 2007, 96, 361-376.
46. Kapsi, S. G.; Ayres, J. W. Processing factors in development of solid solution formulation of itraconazole for enhancement of drug solution and bioavailability. Int. J. Pharm. 2001, 229, 193-203.
47. Jamzad, S.; Fassihi, R. Role of surfactant and pH on dissolution properties of fenofibrate and glipizide-technical note. AAPS PharmSciTech 2006, 7 (2), E1-E6.
48. Waterman, K. C.; Carella, A. J.; Gumkowski, M. J.; Lukulay, P.; MacDonald, B. C.; Roy, M. C.; Shamblin, S. L. Improved Protocol and Data Analysis for Accelerated Shelf-Life Estimation of Solid Dosage Forms. Pharm. Res. 2007, 24 (4), 780-790.